Trimethoprim-Sulfamethoxazole Superior for Abscess

Share this content:
Trimethoprim-Sulfamethoxazole Superior for Abscess
Trimethoprim-Sulfamethoxazole Superior for Abscess

THURSDAY, March 3, 2016 (HealthDay News) -- Trimethoprim-sulfamethoxazole results in a higher clinical cure rate of uncomplicated abscesses than placebo, according to a study published in the March 3 issue of the New England Journal of Medicine.

David A. Talan, M.D., from the University of California in Los Angeles, and colleagues conducted a randomized trial at five U.S. emergency departments to compare trimethoprim-sulfamethoxazole with placebo for outpatients aged older than 12 years with an uncomplicated abscess that was being drained. Of the wound cultures, 45.3 percent were positive for methicillin-resistant Staphylococcus aureus (MRSA).

The researchers found that clinical cure of the abscess occurred in 80.5 percent of the trimethoprim-sulfamethoxazole group and in 73.6 percent of the placebo group in the modified intention-to-treat population (P = 0.005). Clinical cure occurred in 92.9 and 85.7 percent of the groups, respectively, in the per-protocol population (P < 0.001). With respect to most secondary outcomes, trimethoprim-sulfamethoxazole was superior to placebo in the per-protocol population, with lower rates of subsequent surgical draining procedures, skin infections at new sites, and infections in household members at seven to 14 days after treatment. Slightly more gastrointestinal side effects were seen for trimethoprim-sulfamethoxazole versus placebo.

"In settings in which MRSA was prevalent, trimethoprim-sulfamethoxazole treatment resulted in a higher cure rate among patients with a drained cutaneous abscess than placebo," the authors write.

Several authors disclosed financial ties to the pharmaceutical industry.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Ancient Gene Protects Elephants From Cancer

Ancient Gene Protects Elephants From Cancer

The LIF6 gene destroys cells with damaged DNA

Reasons for Undergoing Cosmetic Procedures Explored

Reasons for Undergoing Cosmetic Procedures Explored

Psychological and emotional motivations more likely in patients wanting acne scar tx, tattoo removal

DNR Orders Linked to Increased Mortality in Older Adults

DNR Orders Linked to Increased Mortality in Older ...

Early versus late DNR tied to shorter median length of stay in hospitalized adults aged 65 years and older

is free, fast, and customized just for you!




Already a member?

Sign In Now »